Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of DVS SR in Fibromyalgia Extension Study
NCT00424892Phase 3Completed
- Sponsor
- Pfizer
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of desvenlafaxine in fibromyalgia syndrome (FMS), sponsored by Pfizer. Status: completed.
02
Drugs
desvenlafaxine
03
Conditions
fibromyalgia syndrome (FMS)
Beyond the preview
Go deeper on NCT00424892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00424892.